2cureX investor relations material
Listen to the latest call from 2cureX
2cureX AB operates as a medtech company in Europe. The Company focuses on the development and marketing of medical products used to treat chronic wounds and burns. Its primary product is 2cureX Wound Gel; a wound care treatment that utilizes biocompatible polymer foam matrix technology to create a semi-permeable dressing specifically designed for chronic wounds that promotes healing, protects healthy tissue and helps reduce bacterial colonization. 2cureX AB was incorporated in 2006 and is based in Copenhagen, Denmark.
Ticker
2CUREXCountry
DK